Clinical Trials Directory

Trials / Completed

CompletedNCT02580331

1% Metformin Gel in the Treatment of Class II Furcation Defects

1% Metformin Gel as Local Drug Delivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Government Dental College and Research Institute, Bangalore · Academic / Other
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Accepted

Summary

Metformin (MF), a biguanide group of anti-diabetic drug has been shown to enhance osteoblasts differentiation and inhibit osteoclast differentiation in vitro, thus may exhibit a favourable effect on alveolar bone. The present study aims to explore the efficacy of 1% MF gel as a local drug delivery system in adjunct to scaling and root planing (SRP) for the treatment of Class II furcation defects in comparison with placebo gel.

Detailed description

Background: Metformin (MF), a biguanide group of anti-diabetic drug has been shown to enhance osteoblasts differentiation and inhibit osteoclast differentiation in vitro, thus may exhibit a favourable effect on alveolar bone. The present study aims to explore the efficacy of 1% MF gel as a local drug delivery system in adjunct to scaling and root planing (SRP) for the treatment of Class II furcation defects in comparison with placebo gel. Methods: Sixty four patients with single mandibular buccal class II furcation defects were categorized into two treatment groups: SRP plus 1% MF (group 1) and SRP plus placebo (group 2). Clinical parameters were recorded at baseline, 3 months, 6 months, and 9 months, and radiographic parameters were recorded at baseline, 6 months, and 9 months. Defect fill at baseline, 6 months, and 9 months was calculated on standardized radiographs using image analysis software.

Conditions

Interventions

TypeNameDescription
DRUGSRP and placeboPlacement of placebo gel into classII furcation defects after scaling and root planing
DRUGSRP and 1% metforminPlacement of 1% metformin gel into classII furcation defects after scaling and root planing

Timeline

Start date
2014-11-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2015-10-20
Last updated
2015-10-20

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02580331. Inclusion in this directory is not an endorsement.